MacroGenics' (MGNX) CEO Scott Koenig on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/30/21
MacroGenics Provides Update on Corporate Progress and Second Quarter 2021 Financial ResultsGlobeNewsWire • 07/29/21
MacroGenics (MGNX) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/22/21
MacroGenics Announces Date of Second Quarter 2021 Financial Results Conference CallGlobeNewsWire • 07/22/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNXPRNewsWire • 06/16/21
MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in OncologyGlobeNewsWire • 06/16/21
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual MeetingGlobeNewsWire • 05/19/21
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/30/21
MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial ResultsGlobeNewsWire • 04/29/21
Will MacroGenics (MGNX) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 04/22/21
MacroGenics Announces Date of First Quarter 2021 Financial Results Conference CallGlobeNewsWire • 04/19/21
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel ImmunotherapyPRNewsWire • 04/15/21
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/26/21
MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference CallGlobeNewsWire • 02/18/21
MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with IncyteGlobeNewsWire • 02/11/21
MacroGenics Announces Publication of SOPHIA Trial Results for MARGENZA™ in JAMA OncologyGlobeNewsWire • 01/25/21